| Literature DB >> 28590446 |
Tunde Jurikova1, Jiri Mlcek2, Sona Skrovankova3, Daniela Sumczynski4, Jiri Sochor5, Irena Hlavacova6, Lukas Snopek7, Jana Orsavova8.
Abstract
In recent years, growing attention has been focused on the utilization of natural sources of antioxidants in the prevention of chronic diseases. Black chokeberry (Aronia melanocarpa) represents a lesser known fruit species utilized mainly as juices, purees, jams, jellies and wine, as important food colorants or nutritional supplements. The fruit is valued as a great source of antioxidants, especially polyphenols, such as phenolic acids (neochlorogenic and chlorogenic acids) and flavonoids (anthocyanins, proanthocyanidins, flavanols and flavonols), particularly cyanidin-3-galactoside and cyanidin-3-arabinoside, as well as (-)-epicatechin units. The berries of A. melanocarpa, due to the presence and the high content of these bioactive components, exhibit a wide range of positive effects, such as strong antioxidant activity and potential medicinal and therapeutic benefits (gastroprotective, hepatoprotective, antiproliferative or anti-inflammatory activities). They could be also contributory toward the prevention of chronic diseases including metabolic disorders, diabetes and cardiovascular diseases, because of supportive impacts on lipid profiles, fasting plasma glucose and blood pressure levels.Entities:
Keywords: Aronia melanocarpa; bioactive compounds; black chokeberry; chronic diseases; prevention
Mesh:
Substances:
Year: 2017 PMID: 28590446 PMCID: PMC6152740 DOI: 10.3390/molecules22060944
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Summary of the protective effects of black chokeberry fruit in relation to chronic diseases.
| Effect | Mechanism of Action | Study Model | Sources |
|---|---|---|---|
| Anti-inflammatory | Inhibition of release IL-6,IL-8,IL-10 TNF-α Activation NF-κB, cytokines, PGE2 | Human monocytes, mouse macrophage cells, murine splenocytes | [ |
| Inhibition on nitric oxide production | Mouse macrophage | [ | |
| Antidiabetic | Reduction of gastric mucosal demage | Wister rat model | [ |
| Inhibition of α-glucosidase, lipase and amylase | In vitro model studies | [ | |
| Modulation of multiple pathways associated with insulin signaling | Rats on fructose-rich diet, in vivo, in vitro studies | [ | |
| Restoring of beta cells integrity | In vivo models | [ | |
| Cardioprotective | Lipid metabolism–decrease of cholesterol synthesis | Caco-2-cells | [ |
| -Inhibition of LDL oxidation, lipid peroxidation | Patients with metabolic syndrome | [ | |
| -Increase activity of glutathione peroxidase and catalase, reduction of LDL cholesterol -Inhibition of platelet aggregation, protein carbonylation and thiol oxidation | Mens with hypercholesterolemia | [ | |
| Anticoagulant, antithrombotic -Decrease in fibrin polymerization | Human plasma | [ | |
| -Inhibition of platelet aggregation, protein carbonylation and thiol oxidation | Human plasma, purified fibrinogen | [ | |
| Decrease blood pressure | |||
| -inhibition of angiotensis I-converting enzyme ACE | Patients with metabolic syndrome | [ | |
| Protection of coronary arteries | |||
| Coronary vasoactive, vasoprotective effect | Caco-2-cells | ||
| Decrease oxidative stress—stimulation of endothelial formation of NO | Porcine coronary arteries | ||
| Anticancer | Inhibition of oxidation | Caco-2-cells line | [ |
| Reduction of oxidative stress | Human granulocytes, HeLa cervical tumor line, murine leukemia cells, brest cancer patients | [ | |
| Induction of apoptosis | Lymphoblastic leukemia Jurkat cell line | [ | |
| Blockage at G1/G0 and G2/M phases of cell cycle | Human colon cancer | [ |